04/10/2026
Most owners treat high cost specialty drugs like random bad luck. They are not. They are a strategy problem. Tighten prior auth, step therapy, and site of care, then use SIMRP based benefits to cushion the hit for families so you decide how your company participates in those costs, instead of handing the plan a blank check.
If you want the full breakdown and real examples, watch or listen here:
Blog (deep dive on the strategy):
https://www.abbottfamilyagency.com/what-we-do-blogs/what-can-we-do-about-high-cost-specialty-medications
SoundCloud (quick listen while you work):
https://soundcloud.com/matthew-abbott-243872017/what-can-we-do-about-high-cost?utm_source=clipboard&utm_medium=text&utm_campaign=social_sharing&si=9ab24bd752184fbf982d4cba1b076713
Apple Podcast (for iPhone users):
https://podcasts.apple.com/us/podcast/what-can-we-do-about-high-cost-specialty-medications/id1884117899?i=1000760284539
Spotify (save it to your playlist):
https://open.spotify.com/episode/26gEDkRDR1bZgBDQiOSPIH?si=-JdAqnmRSQiNJDcXB5n2wg&nd=1&dlsi=144a540006df4e25